SKAP2 and acute respiratory distress syndrome: Overall, it is found that tRF‐5004b‐enriched SAPs induce acute lung injury by promoting p65 nuclear translocation to activate ECs, suggesting that tRF‐5004b may be a novel therapeutic target for ARDS.